Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study

<p>Abstract</p> <p>Background</p> <p>The preferred immunosuppressive drug for long term treatment of myasthenia gravis (MG) is azathioprine (AZA). Mycophenolate mofetil (MMF) was suggested as an effective and safe second line alternative to AZA.</p> <p>Metho...

Full description

Bibliographic Details
Main Authors: Hanisch F, Wendt M, Zierz S
Format: Article
Language:English
Published: BMC 2009-08-01
Series:European Journal of Medical Research
Subjects:
mycophenolate mofetil
myasthenia gravis
Online Access:http://www.eurjmedres.com/content/14/8/364

Internet

http://www.eurjmedres.com/content/14/8/364

Similar Items